Consolidated Statements of Stockholders' Equity - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-In Capital	Accumulated Other Comprehensive Income (Loss)	Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2021		20,895,000
Beginning balance at Dec. 31, 2021	$ 136,406	$ 2	$ 279,089	$ 0	$ (142,685)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)		132,000
Issuance of common stock upon exercise of stock options	401		401
Issuance of common stock upon exercise of warrants (in shares)		7,000
Issuance of common stock upon exercise of warrants	55		55
Share-based compensation expense	9,643		9,643
Issuance of shares under the employee stock purchase plan (in shares)		27,000
Issuance of shares under the employee stock purchase plan	323		323
Issuance of common stock to PIPE Investors, net of issuance costs (in shares)		3,374,000
Issuance of common stock to PIPE Investors, net of issuance costs	72,178		72,178
Unrealized gain (loss) on investments, net of tax	(115)			(115)
Net loss	$ (60,513)				(60,513)
Ending balance (in shares) at Dec. 31, 2022	24,435,007	24,435,000
Ending balance at Dec. 31, 2022	$ 158,378	$ 2	361,689	(115)	(203,198)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)	41,633	42,000
Issuance of common stock upon exercise of stock options	$ 78		78
Share-based compensation expense	11,954		11,954
Issuance of shares under the employee stock purchase plan (in shares)		77,000
Issuance of shares under the employee stock purchase plan	408		408
Unrealized gain (loss) on investments, net of tax	142			142
Net loss	$ (65,765)				(65,765)
Ending balance (in shares) at Dec. 31, 2023	24,554,205	24,554,000
Ending balance at Dec. 31, 2023	$ 105,195	$ 2	$ 374,129	$ 27	$ (268,963)